KIORA PHARMACEUTICALS, INC. (KPRX) Free cash flow 2016–2025
KIORA PHARMACEUTICALS, INC. (KPRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.1MFY2025 · since FY2016: -$8.4M → -$10.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.1M | -217.8% |
| FY2024 | $8.6M | +189.5% |
| FY2023 | -$9.6M | +8.4% |
| FY2022 | -$10.4M | +2.9% |
| FY2021 | -$10.7M | -46.4% |
| FY2020 | -$7.3M | +10.0% |
| FY2019 | -$8.2M | +24.9% |
| FY2018 | -$10.9M | -67.0% |
| FY2017 | -$6.5M | +22.7% |
| FY2016 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KPRX financial trends
KPRX RevenueKPRX Net incomeKPRX Net marginKPRX Gross profitKPRX Gross marginKPRX Operating incomeKPRX Operating marginKPRX Operating cash flowKPRX Capital expendituresKPRX Return on equityKPRX Stock buybacksKPRX Dividends paidKPRX Total assetsKPRX Total liabilitiesKPRX Shareholders’ equityKPRX overview →